نتایج جستجو برای: invasive pneumococcal disease ipd

تعداد نتایج: 1608475  

Journal: :Pediatrics 2002
Stephen I Pelton Jerome O Klein

Seven-valent pneumococcal conjugate vaccine (PCV7) was licensed in February 2000. In June 2000, the Advisory Committee on Immunization Practices and the American Academy of Pediatrics recommended the universal administration of pneumococcal conjugate vaccine for all children 23 months of age and younger and for children 24 to 59 months of age who are at high risk for serious pneumococcal diseas...

Journal: :Journal of clinical microbiology 2006
Stuart C Clarke Johanna M Jefferies Andrew J Smith Jim McMenamin Timothy J Mitchell Giles F S Edwards

We sought to determine the potential impact of seven-valent pneumococcal conjugate vaccine on the incidence of invasive pneumococcal disease (IPD) among children in Scotland. Invasive pneumococci from blood and cerebrospinal fluid, isolated between 2000 and 2004 from all children aged less than 5 years in Scotland, were characterized by serotyping. Using reported efficacy data of the seven-vale...

2013
Joon Young Song Jun Yong Choi Jin Soo Lee In-Gyu Bae Young Keun Kim Jang Wook Sohn Yu Mi Jo Won Suk Choi Jacob Lee Kyung Hwa Park Woo Joo Kim Hee Jin Cheong

BACKGROUND Streptococcus pneumoniae causes a broad spectrum of illnesses ranging from mild upper respiratory tract infections to invasive pneumococcal disease (IPD). Quantitative data on the burden of pneumococcal disease, important for the establishment of appropriate vaccination strategies, is currently lacking in adults. METHODS This multicenter, retrospective cohort study was designed to ...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
Jean Gaschignard Corinne Levy Maya Chrabieh Bertrand Boisson Cécile Bost-Bru Stéphane Dauger François Dubos Philippe Durand Joël Gaudelus Dominique Gendrel Christèle Gras Le Guen Emmanuel Grimprel Gaël Guyon Catherine Jeudy Eric Jeziorski Francis Leclerc Pierre-Louis Léger Fabrice Lesage Mathie Lorrot Isabelle Pellier Didier Pinquier Loïc de Pontual Philippe Sachs Caroline Thomas Pierre Tissières Frédéric V Valla Philippe Desprez Véronique Frémeaux-Bacchi Emmanuelle Varon Xavier Bossuyt Robert Cohen Laurent Abel Jean-Laurent Casanova Anne Puel Capucine Picard

BACKGROUND About 10% of pediatric patients with invasive pneumococcal disease (IPD) die from the disease. Some primary immunodeficiencies (PIDs) are known to confer predisposition to IPD. However, a systematic search for these PIDs has never been carried out in children presenting with IPD. METHODS We prospectively identified pediatric cases of IPD requiring hospitalization between 2005 and 2...

2010
Simon Rückinger Mark van der Linden Rüdiger von Kries

BACKGROUND Evidence for protection of preterm born infants from invasive pneumococcal disease (IPD) by 7-valent pneumococcal conjugate vaccination (PCV7) is relatively sparse. Data from randomized trials is based on relatively small numbers of preterm born children. METHODS We report data from active prospective surveillance of IPD in children in Germany. The cohorts of preterm born children ...

Journal: :Communicable diseases intelligence quarterly report 2012
Christina Barry Vicki L Krause Heather M Cook Robert I Menzies

Enhanced surveillance for invasive pneumococcal disease (IPD) was conducted in all Australian states and territories in 2007 and 2008 with comprehensive comparative data available since 2002. There were 1,477 cases of IPD notified to the National Notifiable Diseases Surveillance System in Australia in 2007; a notification rate of 7.0 cases per 100,000 population. In 2008 there were 1,628 cases;...

Journal: :Jornal de pediatria 2008
Sonia M Mattei Luiza Helena Falleiros-Carvalho Nilton J F Cavalcante

OBJECTIVE Invasive pneumococcal disease (IPD) primarily affects children less than 5 years old, the elderly and certain at-risk groups; especially people infected by the human immunodeficiency virus (HIV). The objective of this study was to analyze invasive pneumococcal diseases (IPD) in children and adolescents infected by the human immunodeficiency virus (HIV), with relation to morbidity, the...

Journal: :Journal of preventive medicine and hygiene 2012
P Durando C Alicino D De Florentiis M Martini G Icardi

The wide use of the 7-valent Pneumococcal Conjugate Vaccine (PCV7) determined, during the last decade, a dramatic decline in the incidence of Invasive Pneumococcal Diseases (IPD) in infants and children, and also among the non-vaccinated population through the phenomenon known as "herd protection". Furthermore a significant reduction of some non-IPD, such as Community Acquired Pneumonia (CAP) a...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
David Greenberg Shalom Ben-Shimol

The first 7-valent pneumococcal conjugated vaccine (PCV7) was developed on the basis of data demonstrating that within the United States and other developed countries, the 7 vaccine serotypes were responsible for >80% of invasive pneumococcal disease (IPD) in young children [1]. Indeed, shortly after the introduction of PCV7, a significant and dramatic reduction in IPD rates was observed in man...

2015
Francesca Fortunato Domenico Martinelli Maria Giovanna Cappelli Vanessa Cozza Rosa Prato

In Italy, the effectiveness of pneumococcal universal vaccination in preventing vaccine-type invasive pneumococcal disease (IPD) in the PCV7/PCV13 shifting period was estimated to be 84.3% (95% CI: 84.0-84.6%) in children <5 years. This study aims at corroborating the estimation of both the effectiveness (VE) of PCVs and its impact in reducing pneumococcal diseases. A 1:3 matched-case-control s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید